Hers vs Lemonaid Health: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hers beats Lemonaid Health overall, scoring 7.3/10 vs 7.2/10. Hers is more affordable at $199/mo vs $248/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose Lemonaid Health for users who want a flexible membership with broad medication o.
A side-by-side look at Hers and Lemonaid Health to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#34 of 52The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership, alongside their existing compounded semaglutide and new compounded tirzepatide programs.
Visit HersLemonaid Health
#42 of 52Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).
Visit Lemonaid Health| Feature | Hers | Lemonaid Health |
|---|---|---|
| Our Score | 7.3/10 | 7.2/10 |
| Starting Price | $199/mo | $248/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand | Users who want a flexible membership with broad medication options, $49/mo platform fee + compounded ($199), microdose ($199), or brand-name Zepbound via LillyDirect ($299-449) |
| Ranking | #34 | #42 |
| Get started | Visit Hers | Visit Lemonaid Health |
Pros & Cons Compared
Hers
Pros
- +2026 Novo Nordisk partnership, FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership, read as access, not value
Lemonaid Health
Pros
- +2026 restructure, $49/mo Weight Loss Membership (replaces the old $25/visit model)
- +6-month plan discount, compounded tirzepatide drops to $229/mo on a 6-month commitment
- +Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
- +Established since 2013 with physician-only prescribing and rigorous intake
Cons
- −Membership and medication billed separately, the $49/mo number is just the membership, not all-in
- −Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high, read as access, not value
- −Best compounded pricing requires a 6-month commitment
- −The 23andMe acquisition created some uncertainty about the platform's long-term focus
Our Verdict
Hers edges out Lemonaid Health with a score of 7.3/10 vs 7.2/10. If budget is your priority, Hers starts at $199/mo compared to Lemonaid Health's $248/mo. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose Lemonaid Health if you want: users who want a flexible membership with broad medication options, $49/mo platform fee + compounded ($199), microdose ($199), or brand-name zepbound via lillydirect ($299-449).
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Hers nor Lemonaid Health feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Hers or Lemonaid Health tend to look at next.
- Hers vs Sprout Health$199/mo
- Hers vs Enhance MD$212/mo
- Hers vs MEDVi$179/mo
- Lemonaid Health vs Sprout Health$199/mo
- Lemonaid Health vs Enhance MD$212/mo
- Lemonaid Health vs Found$129/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.